Adage Capital Partners Gp, L.L.C. Geron Corp Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Geron Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 19,725,000 shares of GERN stock, worth $90.1 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
19,725,000
Previous 7,200,000
173.96%
Holding current value
$90.1 Million
Previous $23.8 Million
251.99%
% of portfolio
0.16%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding GERN
# of Institutions
258Shares Held
448MCall Options Held
1.91MPut Options Held
897K-
Black Rock Inc. New York, NY46.6MShares$213 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA46.2MShares$211 Million2.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.9MShares$146 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$124 Million17.06% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y923.9MShares$109 Million12.26% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.73B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...